Information Provided By:
Fly News Breaks for October 5, 2015
BSX
Oct 5, 2015 | 07:30 EDT
Raymond James analyst Jayson Bedford upgraded Boston Scientific to Strong Buy with a $21 price target. Bedford believes Boston Scientific is an underappreciated GARP opportunity blending above average earnings growth with an attractive valuation. The analyst expects growth to accelerate in 2016 from product launches and for multiple expansion.
News For BSX From the Last 2 Days
BSX
I agree to the thefly.com's disclaimer & terms of use
About Privacy Terms of Use

© 1996-2018 TheStreet, Inc., 14 Wall Street, 15th Fl, NY, NY 10005

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.